‘Ct Market Worth Over $5.3 Billion In 2017’ Says Visiongain Report

17 August 2017
Pharma

Visiongain’s new report Global Computed Tomography (CT) Scan Market Forecast 2017-2027: Revenue Prospects by Product (High-Slice CT, Medium Slice CT and Low Slice CT), End-use (Hospitals, Diagnostic Centres) and Geography indicates that the CT Scan market will see over $5.3bn in revenue in 2017.
The lead analyst of the report said:

The CT scan market is expected to grow at a healthy CAGR over the study period. Some of the major factors attributing to the growth of the market are increasing incidence and prevalence of various cardiovascular diseases, neurological disorders, various cancers, and orthopaedic diseases.

Advances in digital imaging technology, rising awareness in regards to screening and early diagnosis of cancer and chronic cardiovascular diseases, growing geriatric population, and increasing public awareness are further expected to fuel market growth. Changes in wealth and lifestyle globally, particularly in the BRICS emerging economies, will lead to a rise in the number of patients with a variety of cancers and the increase in the number of people undergoing CT scans for treatment and diagnosis.

All these factors coupled with the safety concerns with the use of CT scanners will see the market grow at a slow but steady pace over the forecast period. However, lack of adequate insurance coverage and demand for refurbished equipment in developing and underdeveloped regions are expected to restraint market growth during the forecast period.”

The 143-page report contains 85 tables, charts and graphs that add visual analysis in order to explain developing trends within the Computed Tomography market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading CT submarkets, segmented by product type, with forecasts for High, medium and low-slice CT scanning devices. The market is also segmented by end-user, with forecasts for Hospitals, Diagnostic Centres and others.

The 143-page report offers market forecasts and analysis for 13 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 7 companies leading the CT field in detail.

The Global Computed Tomography (CT) Scan Market Forecast 2017-2027: Revenue Prospects by Product (High-Slice CT, Medium Slice CT and Low Slice CT), End-use (Hospitals, Diagnostic Centres) and Geography report will be of value to anyone who wants to better understand the Computed Tomography market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the CT Scanning industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever